CFO
DXCM icon

CVA Family Office’s DexCom DXCM Stock Holding History

CVA Family Office’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$45.8K Sell
680
-38
-5% -$2.53K ﹤0.01% 623
2026
Q1 		$45.1K Buy
718
+268
+60% +$18.7K ﹤0.01% 619
2025
Q4 		$29.9K Buy
450
+147
+49% +$9.5K ﹤0.01% 624
2025
Q3 		$20.4K Sell
303
-290
-49% -$22.9K ﹤0.01% 689
2025
Q2 		$51.8K Buy
593
+80
+16% +$6.27K 0.01% 542
2025
Q1 		$35K Sell
513
-341
-40% -$27.8K 0.01% 579
2024
Q4 		$66.4K Buy
854
+684
+402% +$50.6K 0.01% 461
2024
Q3 		$11.4K Sell
170
-643
-79% -$52.8K ﹤0.01% 739
2024
Q2 		$92.2K Buy
813
+4
+0.5% +$506 0.02% 367
2024
Q1 		$112K Buy
809
+4
+0.5% +$503 0.02% 338
2023
Q4 		$99.9K Buy
+805
New +$82.2K 0.02% 334
2023
Q3 		– Sell
-890
Closed -$114K – 430
2023
Q2 		$114K Hold
890
– – 0.02% 289
2023
Q1 		$103K Buy
890
+30
+3% +$3.36K 0.02% 305
2022
Q4 		$97.4K Buy
860
+300
+54% +$32.9K 0.02% 296
2022
Q3 		$45K Buy
560
+230
+70% +$19.5K 0.01% 395
2022
Q2 		$25K Sell
330
-330
-50% -$30.1K 0.01% 499
2022
Q1 		$84K Sell
660
-160
-20% -$17.5K 0.02% 292
2021
Q4 		$110K Buy
+820
New +$118K 0.03% 237
2021
Q3 		– Sell
-816
Closed -$87K – 505
2021
Q2 		$87K Buy
816
+596
+271% +$57.2K 0.02% 258
2021
Q1 		$20K Buy
+220
New +$20.7K 0.01% 414

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

CVA Family Office's DXCM Position: Q2 2026 in Review

CVA Family Office reduced its DexCom (DXCM) stake by 5.3% in Q2 2026, selling an estimated $2.53K and leaving 680 shares worth $45.8K. The position accounts for ﹤0.01% of the portfolio, ranked #623.

CVA Family Office first reported a position in DXCM in Q1 2021 and has held it in 20 quarters since. The position peaked at $114K in Q2 2023. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • CVA Family Office held 680 shares of DexCom worth $45.8K as of Q2 2026.
  • CVA Family Office sold 38 DexCom shares in Q2 2026, an estimated $2.53K.
  • DexCom made up ﹤0.01% of CVA Family Office's portfolio in Q2 2026, its #623 holding.
  • CVA Family Office first reported a position in DexCom in Q1 2021 and has held it in 20 quarters since.
  • CVA Family Office's DexCom position peaked at $114K in Q2 2023.
  • 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on CVA Family Office's 13F filing for Q2 2026, filed 7 Aug 2026.